{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T05:48:02Z","timestamp":1791697682906,"version":"4.3.4"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Hypertensive disorders of pregnancy (HDP) are among the leading causes of maternal morbidity and mortality worldwide and an increasing global concern. This review aimed to estimate the global prevalence of HDP by country and World Health Organization (WHO) region using nationally representative, population-based studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed and Embase for articles published between January 2004 and December 2023 and included population-based, observational studies with nationally or internationally representative samples reporting primary data on HDP prevalence. Study quality was assessed using a modified version of the Newcastle-Ottawa Scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 143 studies from 31 countries across six WHO regions met the inclusion criteria. The African Region reported the highest prevalence of chronic hypertension (4.80%), gestational hypertension (17.50%), and composite HDP (22.20%), although nationally representative prevalence estimates for preeclampsia and eclampsia were not available for this region. In contrast, the Eastern Mediterranean Region reported the lowest rates of chronic hypertension (1.10%), gestational hypertension (1.70%), preeclampsia (1.45%), and HDP (5.10%). The European Region had intermediate rates of chronic hypertension (1.70%), gestational hypertension (2.90%), preeclampsia (2.50%), eclampsia (0.02%) and HDP (5.90%). The Americas Region and the Western Pacific Region had varying rates across the HDP spectrum: chronic hypertension (2.35%, 3.15%), gestational hypertension (5.10%, 1.98%), preeclampsia (5.35%, 2.45%), eclampsia (0.08%, 0.06%), and HDP (8.04%, 5.60%, respectively). High-income countries had more studies of higher methodological quality than low- and middle-income countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>We observed considerable variability in HDP prevalence and study quality across countries and regions. This may stem from variations in screening methods, diagnostic criteria, and data availability, highlighting critical gaps in standardized protocols particularly in resource-limited settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1692590","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:49:47Z","timestamp":1776836987000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Global prevalence of hypertensive disorders of pregnancy: a scoping review and global perspective by country and region"],"prefix":"10.3389","volume":"13","author":[{"given":"Yunjie","family":"Li","sequence":"first","affiliation":[{"name":"Kaiser Permanente Bernard J. Tyson School of Medicine","place":["Pasadena, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana F.","family":"Chehab","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California","place":["Pleasanton, CA, United States"]},{"name":"Kaiser Permanente Northern California, Center for Upstream Prevention of Adiposity and Diabetes Mellitus (UPSTREAM)","place":["Pleasanton, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Z.","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California","place":["Pleasanton, CA, United States"]},{"name":"Kaiser Permanente Northern California, Center for Upstream Prevention of Adiposity and Diabetes Mellitus (UPSTREAM)","place":["Pleasanton, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sita Manasa","family":"Susarla","sequence":"additional","affiliation":[{"name":"School of Public Health, University of California, Berkeley","place":["Berkeley, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Voong","sequence":"additional","affiliation":[{"name":"School of Public Health, University of California, Berkeley","place":["Berkeley, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Public Health, Columbia University","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana C.","family":"Cabatu","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Bernard J. Tyson School of Medicine","place":["Pasadena, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadley","family":"Sorsby-Jones","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Bernard J. Tyson School of Medicine","place":["Pasadena, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeyi","family":"Zhu","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Bernard J. Tyson School of Medicine","place":["Pasadena, CA, United States"]},{"name":"Division of Research, Kaiser Permanente Northern California","place":["Pleasanton, CA, United States"]},{"name":"Kaiser Permanente Northern California, Center for Upstream Prevention of Adiposity and Diabetes Mellitus (UPSTREAM)","place":["Pleasanton, CA, United States"]},{"name":"Department of Epidemiology & Biostatistics, University of California","place":["San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccl.2020.09.005","article-title":"Hypertensive disorders of pregnancy","volume":"39","author":"Khedagi","year":"2021","journal-title":"Cardiol Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/AOG.0000000000004824","article-title":"Trends in hypertensive disorders of pregnancy in the United States from 1989 to 2020","volume":"140","author":"Bruno","year":"2022","journal-title":"Obstet Gynecol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet Lond Engl"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41598-025-85819-0","article-title":"Trends in global and regional incidence and prevalence of hypertensive disorders in pregnancy (1990\u20132021): an age-period-cohort analysis","volume":"15","author":"Sun","year":"2025","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"134.e1","DOI":"10.1016\/j.ajog.2011.10.878","article-title":"Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions","volume":"206","author":"Bateman","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41574-022-00734-y","article-title":"A global view of hypertensive disorders and diabetes mellitus during pregnancy","volume":"18","author":"Jiang","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12884-021-03809-2","article-title":"Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B11","volume-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analysis","author":"Wells","year":"2011"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1097\/AOG.0000000000003020","article-title":"ACOG Practice Bulletin No. 203: chronic hypertension in pregnancy","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"B14","volume-title":"Hypertension in Pregnancy: Diagnosis and Management. NICE Guideline","year":"2019"},{"key":"B15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jogc.2022.03.002","article-title":"Guideline No. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management","volume":"44","author":"Magee","year":"2022","journal-title":"J Obstet Gynaecol Can"},{"key":"B16","doi-asserted-by":"publisher","first-page":"582","DOI":"10.5694\/mja2.52312","article-title":"A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline","volume":"220","author":"Shanmugalingam","year":"2024","journal-title":"Med J Aust"},{"key":"B17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"B18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1701-2163(15)30533-8","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary","volume":"36","author":"Magee","year":"2014","journal-title":"J Obstet Gynaecol Can JOGC"},{"key":"B19","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.cjca.2018.02.021","article-title":"Hypertension Canada\u2019s 2018 guidelines for the management of hypertension in pregnancy","volume":"34","author":"Butalia","year":"2018","journal-title":"Can J Cardiol"},{"key":"B20","article-title":"World Bank country and lending groups","year":""},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2023.4934","volume-title":"Screening for Hypertensive Disorders of Pregnancy: An Evidence Update for the U.S. Preventive Services Task Force","author":"Henderson","year":"2023"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e59133","DOI":"10.7759\/cureus.59133","article-title":"Comparison of pre-eclampsia screening algorithms in the first trimester of pregnancy being used in Thai Nguyen Province","volume":"16","author":"Huong","year":"2024","journal-title":"Cureus"},{"key":"B23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ijgo.14100","article-title":"Maternal and perinatal complications according to maternal age: a systematic review and meta-analysis","volume":"159","author":"Saccone","year":"2022","journal-title":"Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/1471-0528.12659","article-title":"Advanced maternal age and pregnancy outcomes: a multicountry assessment","volume":"121","author":"Laopaiboon","year":"2014","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"100773","DOI":"10.1016\/j.ajogmf.2022.100773","article-title":"Neighborhood disadvantage and the racial disparity in postpartum hypertension","volume":"5","author":"Lemon","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.18082","article-title":"Towards the development of a conceptual framework of the determinants of pre-eclampsia: a hierarchical systematic review of social determinants","author":"Kinshella","year":"2025","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMp1802313","article-title":"Making neighborhood-disadvantage metrics accessible - the neighborhood atlas","volume":"378","author":"Kind","year":"2018","journal-title":"N Engl J Med"},{"key":"B28","article-title":"Proportion of population below the international poverty line (SDG 1.1.1)","year":""},{"key":"B29","first-page":"46","volume-title":"Access and Health Expenditure for Ethnic\/Racial Groups in the Region of the Americas","author":"Parodi","year":"2010"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0175914","DOI":"10.1371\/journal.pone.0175914","article-title":"Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia","volume":"12","author":"Shen","year":"2017","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J Clin Epidemiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1692590\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:49:49Z","timestamp":1776836989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1692590\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":31,"alternative-id":["10.3389\/fcvm.2026.1692590"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1692590","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"1692590"}}